Targeting a surface cavity of alpha 1-antitrypsin to prevent conformational disease (Q44478799)

3 December 2017

Targeting a surface cavity of alpha 1-antitrypsin to prevent conformational disease (English)

1 reference

3 December 2017

5

1 reference

3 December 2017

Helen Parfrey

1

1 reference

3 December 2017

Ravi Mahadeva

2

1 reference

3 December 2017

Neil A Ravenhill

3

1 reference

3 December 2017

Aiwu Zhou

4

1 reference

3 December 2017

Richard C Foreman

6

1 reference

3 December 2017

David A Lomas

7

1 reference

3 December 2017

language of work or name

English

0 references

publication date

13 June 2003

1 reference

Journal of Biological Chemistry

3 December 2017

1 reference

3 December 2017

278

1 reference

3 December 2017

35

1 reference

3 December 2017

33060-33066

1 reference

3 December 2017

Conformational disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Alpha1-antitrypsin deficiency--a model for conformational diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

The mechanism of Z alpha 1-antitrypsin accumulation in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Wild-type alpha 1-antitrypsin is in the canonical inhibitory conformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

The native strains in the hydrophobic core and flexible reactive loop of a serine protease inhibitor: crystal structure of an uncleaved alpha1-antitrypsin at 2.7 A

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

A 2.1 A resolution structure of an uncleaved alpha(1)-antitrypsin shows variability of the reactive center and other loops

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

alpha 1-Antitrypsin Mmalton (Phe52-deleted) forms loop-sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Mutations which impede loop/sheet polymerization enhance the secretion of human alpha 1-antitrypsin deficiency variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Topography of a 2.0 Å structure of α1-antitrypsin reveals targets for rational drug design to prevent conformational disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

The serpin inhibitory mechanism is critically dependent on the length of the reactive center loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Assessment of the functional integrity of the humoral immune response: the plaque-forming cell assay and the enzyme-linked immunosorbent assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

What do dysfunctional serpins tell us about molecular mobility and disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Structural transition of alpha 1-antitrypsin by a peptide sequentially similar to beta-strand s4A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Influenza hemagglutinin is spring-loaded by a metastable native conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Regulation of protein function by native metastability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Cavities of alpha(1)-antitrypsin that play structural and functional roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

α1-Antitrypsin Polymerisation Can Occur by both Loop A and C Sheet Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

A Kinetic Mechanism for the Polymerization of α1-Antitrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Pathogenic α1-Antitrypsin Polymers Are Formed by Reactive Loop-β-Sheet A Linkage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Amino acid substitution Glu→Lys in α1-antitrypsin PiZ

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

The natural history of liver disease in alpha 1-antitrypsin deficient children

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Detection of circulating and endothelial cell polymers of Z and wild type alpha 1-antitrypsin by a monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Structural explanation for the deficiency of S alpha 1-antitrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

A thermostable mutation located at the hydrophobic core of alpha 1-antitrypsin suppresses the folding defect of the Z-type variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Inhibitory mechanism of serpins. Mobility of the C-terminal region of the reactive-site loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Metastability in the inhibitory mechanism of human alpha1-antitrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Distribution of the native strain in human alpha 1-antitrypsin and its association with protease inhibitor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Xenopusoocytes can synthesise but do not secrete the Z variant of human α1-antitrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Prevention of polymerization of M and Z alpha1-Antitrypsin (alpha1-AT) with trimethylamine N-oxide. Implications for the treatment of alpha1-at deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

Arrest of beta-amyloid fibril formation by a pentapeptide ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302646200

21 January 2018

Identifiers

DOI

10.1074/JBC.M302646200

1 reference

3 December 2017

1 reference